Cargando…
Updates on enhanced recovery after surgery for radical cystectomy
Enhanced Recovery after Surgery (ERAS) is a multimodal pathway that provides evidence-based guidance for improving perioperative care and outcomes in patients undergoing surgery. In 2013, the ERAS society released its original guidelines for radical cystectomy (RC) for bladder cancer (BC), adopting...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280843/ https://www.ncbi.nlm.nih.gov/pubmed/35844831 http://dx.doi.org/10.1177/17562872221109022 |
_version_ | 1784746742372106240 |
---|---|
author | Lee, Grace Patel, Hiren V. Srivastava, Arnav Ghodoussipour, Saum |
author_facet | Lee, Grace Patel, Hiren V. Srivastava, Arnav Ghodoussipour, Saum |
author_sort | Lee, Grace |
collection | PubMed |
description | Enhanced Recovery after Surgery (ERAS) is a multimodal pathway that provides evidence-based guidance for improving perioperative care and outcomes in patients undergoing surgery. In 2013, the ERAS society released its original guidelines for radical cystectomy (RC) for bladder cancer (BC), adopting much of its supporting data from colorectal literature. In the last decade, growing interest in ERAS has increased RC-specific ERAS research, including prospective randomized controlled trials (RCTs). Collective data suggest ERAS contributes to improved complication rates, decreased hospital length-of-stay, and/or time to bowel recovery. Various institutions have adopted modified versions of the ERAS pathway, yet there remains a lack of consensus on the efficacy of specific ERAS items and standardization of the protocol. In this review, we summarize updated evidence and practice patterns of ERAS pathways for RC since the introduction of the original 2013 guidelines. Novel target interventions, including use of immunonutrition, prehabilitation, alvimopan, and methods of local analgesia are reviewed. Finally, we discuss barriers to implementing and future steps in advancing the ERAS movement. |
format | Online Article Text |
id | pubmed-9280843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-92808432022-07-15 Updates on enhanced recovery after surgery for radical cystectomy Lee, Grace Patel, Hiren V. Srivastava, Arnav Ghodoussipour, Saum Ther Adv Urol Management of Bladder Cancer: What is the Evidence? Enhanced Recovery after Surgery (ERAS) is a multimodal pathway that provides evidence-based guidance for improving perioperative care and outcomes in patients undergoing surgery. In 2013, the ERAS society released its original guidelines for radical cystectomy (RC) for bladder cancer (BC), adopting much of its supporting data from colorectal literature. In the last decade, growing interest in ERAS has increased RC-specific ERAS research, including prospective randomized controlled trials (RCTs). Collective data suggest ERAS contributes to improved complication rates, decreased hospital length-of-stay, and/or time to bowel recovery. Various institutions have adopted modified versions of the ERAS pathway, yet there remains a lack of consensus on the efficacy of specific ERAS items and standardization of the protocol. In this review, we summarize updated evidence and practice patterns of ERAS pathways for RC since the introduction of the original 2013 guidelines. Novel target interventions, including use of immunonutrition, prehabilitation, alvimopan, and methods of local analgesia are reviewed. Finally, we discuss barriers to implementing and future steps in advancing the ERAS movement. SAGE Publications 2022-07-12 /pmc/articles/PMC9280843/ /pubmed/35844831 http://dx.doi.org/10.1177/17562872221109022 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Management of Bladder Cancer: What is the Evidence? Lee, Grace Patel, Hiren V. Srivastava, Arnav Ghodoussipour, Saum Updates on enhanced recovery after surgery for radical cystectomy |
title | Updates on enhanced recovery after surgery for radical cystectomy |
title_full | Updates on enhanced recovery after surgery for radical cystectomy |
title_fullStr | Updates on enhanced recovery after surgery for radical cystectomy |
title_full_unstemmed | Updates on enhanced recovery after surgery for radical cystectomy |
title_short | Updates on enhanced recovery after surgery for radical cystectomy |
title_sort | updates on enhanced recovery after surgery for radical cystectomy |
topic | Management of Bladder Cancer: What is the Evidence? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280843/ https://www.ncbi.nlm.nih.gov/pubmed/35844831 http://dx.doi.org/10.1177/17562872221109022 |
work_keys_str_mv | AT leegrace updatesonenhancedrecoveryaftersurgeryforradicalcystectomy AT patelhirenv updatesonenhancedrecoveryaftersurgeryforradicalcystectomy AT srivastavaarnav updatesonenhancedrecoveryaftersurgeryforradicalcystectomy AT ghodoussipoursaum updatesonenhancedrecoveryaftersurgeryforradicalcystectomy |